Exploring the relationship between gut microbiota and the efficacy of antidepressant treatment in patients with depressio

Phase 1

• Conditions: Major Depressive Disorder; MedDRA version: 21.1Level: LLTClassification code 10081270Term: Major depressive disorderSystem Organ Class: 100000004873; Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]

• Registration Number: EUCTR2021-006510-36-NL
• Lead Sponsor: Radboudumc

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-21
• Last Update Posted: 10 January 2022

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Aged = 18
Main diagnosis of unipolar depression
Indication for the prescription of an antidepressant
Starting a new SSRI/SNRI or TCA antidepressant treatment
Having already used one or more antidepressants without effect and/or with side-effects

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 25
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 999

Exclusion Criteria

Use of antibiotics in a period of three months prior to the baseline visit
Currently pregnant or breastfeeding

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified